Compare

Johnson & Johnson vs Pfizer

Johnson & Johnson (JNJ) and Pfizer (PFE) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.

Johnson & Johnson JNJNYSE · PharmaceuticalsPfizer PFENYSE · Pharmaceuticals
Insider records, last 12 months280110
Congress trades, last 12 months2511
Fund positions reported, last 12 months587207
Federal contract awards, last 12 months1610
Open-market purchases by insiders since 20062525
Open-market sales by insiders since 2006440880
Last open-market purchase by an insiderDec 1, 2025Aug 12, 2026
Next resultsOct 13, 2026Nov 3, 2026

Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.

Common questions

Which has had more insider buying, Johnson & Johnson or Pfizer?

Since 2006, insiders of both companies reported 25 open-market purchases, in SEC Forms 4 and 5.

Do members of Congress trade JNJ or PFE?

In the last 12 months, members of Congress disclosed 25 trades in Johnson & Johnson (JNJ) and 11 in Pfizer (PFE), each reported as a value range on a periodic transaction report.

When did insiders last buy JNJ and PFE?

Johnson & Johnson: Dec 1, 2025. Pfizer: Aug 12, 2026. Dates are those of the SEC filings.

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Johnson & Johnson free$9.99 a month, cancel anytime

Johnson & Johnson pagePfizer pageRare insider trades this weekAll comparisons

https://oqro.io/compare/jnj-vs-pfe